John Devane
27Patents
8h-index
28Co-inventors
75Inventor score
Filing activity: Jun 22, 1999 → Nov 14, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6228398A | Multiparticulate modified release composition | Human Necessities | 358 | Expired |
| US6730325B2 | Multiparticulate modified release composition | Human Necessities | 220 | Expired |
| US6902742B2 | Multiparticulate modified release composition | Human Necessities | 176 | Expired |
| US6793936B2 | Multiparticulate modified release composition | Human Necessities | 154 | Expired |
| US8293277B2 | Controlled-release nanoparticulate compositions | Human Necessities | 43 | Expired |
| US7413751B2 | Methods of treatment using a gastric retained losartan dosage | Human Necessities | 25 | Expired |
| US7737133B2 | Formulations and methods of treating inflammatory bowel disease | Chemistry; Metallurgy | 15 | Expired |
| US8119163B2 | Nanoparticulate and controlled release compositions comprising cefditoren | Human Necessities | 12 | Active |
| US10792262B1 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | Human Necessities | 5 | Active |
| US6849661B2 | Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil | Human Necessities | 2 | Expired |
| US7928092B2 | Formulations and methods of treating inflammatory bowel disease | Chemistry; Metallurgy | 1 | Active |
| US9040591B2 | Methods and compositions comprising at least one α3 βA4 nAChR antagonist or pharmaceutically acceptable salt thereof | Human Necessities | 1 | Active |
| US11491125B1 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | Human Necessities | 1 | Active |
| US11654124B2 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | Human Necessities | 1 | Active |
| US8987322B2 | Pharmaceutical formulations for carrier-mediated transport statins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7825106B2 | Modified release formulations and methods of treating inflammatory bowel disease | Chemistry; Metallurgy | 0 | Active |
| US11083694B2 | Injectable phenol formulations and methods of their use | Human Necessities | 0 | Active |
| US12011502B2 | Compositions and methods of administering baclofen | Human Necessities | 0 | Active |
| US6967218B2 | Pravastatin pharmaceutical formulations and methods of their use | Human Necessities | 0 | Expired |
| US10751312B1 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | General | 0 | Revoked |
| US11931328B2 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | Human Necessities | 0 | Active |
| US10959962B2 | Injectable phenol formulations and methods of their use | Human Necessities | 0 | Active |
| US11523984B1 | Compositions and methods of administering baclofen | Human Necessities | 0 | Active |
| US12383522B2 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | Human Necessities | 0 | Active |
| US11083695B2 | Injectable phenol formulations and methods of manufacture | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.